Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioVerdant
San Diego, California, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
BioVerdant was a biotechnology company focused on developing biocatalysis and green chemistry solutions for the pharmaceutical industry. The company specialized in the discovery and optimization of enzymes to enable the efficient synthesis of complex chiral intermediates and active pharmaceutical ingredients (APIs). Its technology aimed to replace traditional chemical synthesis with more sustainable, cost-effective, and environmentally friendly biological processes. BioVerdant was acquired by Codexis in 2010 to strengthen its position in the pharmaceutical manufacturing market and expand its portfolio of biocatalytic tools.
- Modalities
- Small moleculeEnzymesBiologic
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on BioVerdant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioVerdant.